Copyright © 2021. Inderes Oyj. All rights reserved.

Innofactor

Viimeisimmät raportit

Laaja raportti

Analyytikko

Joni Grönqvist

Joni Grönqvist

Analyytikko

Lisätiedot

Viimeisin video

Sisäpiirin kaupat

Nettovaikuttavuus

Muut analyysit
27.4.
2022

Innofactor’s revenue development in Q1 was weakened by increased absences due to sickness, while profitability climbed back to rather healthy levels. Signs of clear pick-up in growth remain limited but potential exists.

Muut analyysit
26.4.
2022

Innofactor’s Q1 results were slightly better than expected.

Muut analyysit
18.2.
2022

Innofactor’s Q4 fell well short of our expectations as the company saw challenges relating to organizational changes and employee turnover. We have lowered our 2022 estimates and our TP to EUR 1.6 (2.1), BUY-rating intact.

Muut analyysit
17.2.
2022

Innofactor’s Q4 results were below our expectations. Net sales amounted to EUR 17.5m (Evli EUR 18.6m), while EBITDA amounted to EUR 1.7m (Evli EUR 2.6m).

Muut analyysit
27.10.
2021

Innofactor’s Q3 profitability remained at good levels but growth was not quite as good as expected due to organizational restructuring causing a sales dip in Finland.

Muut analyysit
26.10.
2021

Innofactor’s Q3 results were close to our expectations. Net sales amounted to EUR 13.7m (Evli EUR 14.5m), while EBITDA amounted to EUR 1.7m (Evli EUR 1.8m).

Muut analyysit
23.7.
2021

Q2 well in line with our expectationsInnofactor reported its Q2 results, which were well in line with our expectations. Revenue grew 3.2% y/y, 7.6% organically, to EUR 17.3m (Evli 17.3m). Revenue growth turned positive again in all countries.

Muut analyysit
22.7.
2021

Innofactor’s Q2 results were as expected. Net sales amounted to EUR 17.3m (Evli EUR 17.3m), while EBITDA amounted to EUR 2.1m (Evli EUR 2.2m). The order backlog continued to grow well, up 28% y/y to EUR 72.7m.

Muut analyysit
28.4.
2021

Q1 well in line with our estimatesInnofactor reported Q1 results that were well in line with our expectations. Revenue grew 3.8% to EUR 17.8m (Evli EUR 17.9m) while EBITDA amounted to EUR 4.7m (Evli EUR 4.8m).

Muut analyysit
27.4.
2021

Innofactor’s Q1 results were in line with our expectations. Net sales amounted to EUR 17.8m (Evli EUR 17.9m), while EBITDA amounted to EUR 4.7m (Evli EUR 4.8m). EBITDA included a one-off of approx. EUR 2.6m related to the Prime business divestment.Guidance reiterated: Innofactor’s net sales and EBITDA in 2021 are estimated to increase compared to 2020 (net sales and EBITDA EUR 66.3m and EUR 7.2m respectively).Rating; buy, target price 2,2 EUR

Innofactor